Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians

Immunotherapy using immune checkpoint inhibitors (ICIs) is a breakthrough in oncology development and has been applied to multiple solid tumors. However, unlike traditional cancer treatment approaches, immune checkpoint inhibitors (ICIs) initiate indirect cytotoxicity by generating inflammation, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Huijie, Luo, Qian, Wu, Wanchun, Li, Na, Yang, Chunli, Zou, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014595/
https://www.ncbi.nlm.nih.gov/pubmed/36936913
http://dx.doi.org/10.3389/fimmu.2023.1088874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014595/
https://www.ncbi.nlm.nih.gov/pubmed/36936913
http://dx.doi.org/10.3389/fimmu.2023.1088874

Ejemplares similares